Ernexa Therapeutics Inc.
ERNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000748592
No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.
Other share classesERNAW
13F holders, Q2 2025
Institutional positions in Ernexa Therapeutics Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −15 vs. Q1 2025
- Shares held
- 49.8K
- −49.4K (−49.8%) vs. Q1 2025Converted for a 1-for-15 split
- Total value
- $91.7K
- −$172.5K (−65.3%) vs. Q1 2025
- New holders
- 1
- 4 more added
- Sold out
- 16
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $236.2K |
| Q1 2026 | 20 | $711.4K |
| Q4 2025 | 14 | $627.1K |
| Q3 2025 | 14 | $566.0K |
| Q2 2025 | 12 | $91.7K |
| Q1 2025 | 27 | $264.2K |
| Q4 2024 | 24 | $292.4K |
| Q3 2024 | 20 | $746.9K |
| Q2 2024 | 20 | $712.4K |
| Q1 2024 | 23 | $981.1K |
| Q4 2023 | 20 | $636.9K |
| Q3 2023 | 22 | $728.4K |
| Q2 2023 | 20 | $750.2K |
| Q1 2023 | 21 | $1.14M |
| Q4 2022 | 20 | $1.19M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Ernexa Therapeutics Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 20,075 | $36.9K | 0.00% | +532+2.7% | AddedConverted for a 1-for-15 split |
| CI Private Wealth, LLC | 17,523 | $32.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Sippican Capital Advisors | 10,000 | $18.4K | 0.01% | +4,667+87.5% | AddedConverted for a 1-for-15 split |
| BlackRock, Inc. | 820 | $1.51K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Morgan Stanley | 554 | $1.02K | 0.00% | +554 | New |
| UBS Group AG | 548 | $1.01K | 0.00% | −284−34.1% | ReducedConverted for a 1-for-15 split |
| Assetmark, Inc | 133 | $245 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| EverSource Wealth Advisors, LLC | 116 | $213 | 0.00% | −1−0.8% | ReducedConverted for a 1-for-15 split |
| Bank of America Corp | 21 | $39 | 0.00% | +0+1.9% | AddedConverted for a 1-for-15 split |
| BNP Paribas Arbitrage, SA | 10 | $18 | 0.00% | +1+7.1% | AddedConverted for a 1-for-15 split |
| Montag A & Associates Inc | 8 | $15 | 0.00% | −1−14.9% | ReducedConverted for a 1-for-15 split |
| Activest Wealth Management | 3 | $6 | 0.00% | −0−10.0% | ReducedConverted for a 1-for-15 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,289−100.0% | Sold outConverted for a 1-for-15 split |
| Citigroup Inc | 0 | $0 | 0.00% | −10,210−100.0% | Sold outConverted for a 1-for-15 split |
| Cypress Point Wealth Management, LLC | 0 | $0 | 0.00% | −6,292−100.0% | Sold outConverted for a 1-for-15 split |
| JustInvest LLC | 0 | $0 | 0.00% | −4,508−100.0% | Sold outConverted for a 1-for-15 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,371−100.0% | Sold outConverted for a 1-for-15 split |
| Naviter Wealth, LLC | 0 | $0 | 0.00% | −3,151−100.0% | Sold outConverted for a 1-for-15 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −2,759−100.0% | Sold outConverted for a 1-for-15 split |
| HRT Financial LP | 0 | $0 | 0.00% | −2,833−100.0% | Sold outConverted for a 1-for-15 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −2,546−100.0% | Sold outConverted for a 1-for-15 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,203−100.0% | Sold outConverted for a 1-for-15 split |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −987−100.0% | Sold outConverted for a 1-for-15 split |
| one8zero8, LLC | 0 | $0 | 0.00% | −725−100.0% | Sold outConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −4−100.0% | Sold outConverted for a 1-for-15 split |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |
| FMR LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |